How Scientists Are Engineering Living Tissue to Heal Wounds
Imagine a future where severe burns and chronic wounds could be healed with a patient's own cells, rather than through painful skin grafts that create additional injuries. This isn't science fiction—it's the cutting edge of tissue engineering that's transforming how we approach wound healing. At the forefront of this medical revolution is the development of bioengineered skin substitutes that harness the body's own healing mechanisms in ways never before possible.
For decades, the gold standard treatment for full-thickness skin wounds (those that damage both epidermal and dermal layers) has been split-skin grafting (SSG). While often effective, this approach has significant limitations—particularly for patients with extensive burns who lack sufficient healthy donor skin. The process can be painful, creates additional wounds, and may still result in poor cosmetic outcomes with severe scarring 1 2 .
To appreciate the engineering challenge, we must first understand the skin's sophisticated structure. Our skin is the body's largest organ, comprising about 15% of total body weight, and serves as our first-line protective barrier against environmental threats while preventing water loss and regulating temperature 2 .
The outermost layer, dominated by keratinocytes that undergo a continuous cycle of proliferation, differentiation, and shedding. These remarkable cells migrate from the basal layer upward, eventually forming the protective stratum corneum before being shed—a process that takes approximately 20-30 days 2 .
The thicker underlying layer containing dermal fibroblasts that produce and remodel the extracellular matrix (ECM)—the complex network of proteins including collagen and elastin that provides structural support and regulates cell behavior 4 .
When both layers are damaged in full-thickness wounds, the body's natural healing process becomes overwhelmed, making external intervention necessary. Traditional skin grafts transfer healthy skin from one area to another, but tissue engineering offers a more sophisticated approach by creating customized skin substitutes using a patient's own cells 1 2 .
The skin's protective barrier cells
Architects of skin structure
Natural scaffolding material
Keratinocytes are the workhorses of the epidermis, constituting the most abundant cell type in the skin. These remarkable cells don't merely provide structure—they actively participate in wound healing through several sophisticated mechanisms:
Dermal fibroblasts serve as the primary ECM architects in wound healing, responsible for depositing and remodeling the structural framework that supports skin regeneration. These cells perform several critical functions:
Fibrin, a natural protein formed during blood clotting, provides an ideal biomaterial scaffold for tissue engineering. Its advantages include:
The dynamic interplay between keratinocytes and fibroblasts is essential for effective wound healing. These cells communicate through complex biochemical signals, creating a coordinated response that restores skin integrity 4 .
A pivotal 2014 study published in Advances in Skin & Wound Care directly compared the effectiveness of different tissue-engineered skin substitutes using a sheep model—an animal whose skin healing mechanisms closely resemble humans 1 5 .
The research team designed a sophisticated experiment to answer a critical question: which configuration would most effectively promote full-thickness wound healing—a bilayered construct containing both keratinocytes and fibroblasts, or single-layered substitutes containing just one cell type?
| Group Abbreviation | Construct Type | Cellular Components | Biomaterial Scaffold |
|---|---|---|---|
| BTES | Bilayered tissue-engineered skin | Keratinocytes + Fibroblasts | Autologous fibrin |
| SLTES-K | Single-layer tissue-engineered skin | Keratinocytes only | Autologous fibrin |
| SLTES-F | Single-layer tissue-engineered skin | Fibroblasts only | Autologous fibrin |
| Control | None | Natural healing | None |
The process of creating these tissue-engineered skin substitutes represents a remarkable fusion of biology and engineering:
The process begins with a small full-thickness skin biopsy harvested from the patient (or in this case, sheep). This minimally invasive procedure provides the cellular raw material without creating significant additional wounds 1 .
- Fibroblasts were cultured using Ham's F12: Dulbecco modified Eagle medium supplemented with 10% fetal bovine serum
- Keratinocytes were cultured using Defined Keratinocytes Serum Free Medium 1
- This expansion process allows a small number of initially harvested cells to multiply into the quantities needed for tissue engineering
The cultured cells were combined with autologous fibrin to create the three-dimensional skin substitutes. The bilayered construct was carefully engineered to place fibroblasts in the dermal-like layer and keratinocytes in the epidermal-like layer, mimicking natural skin architecture 1 .
The engineered substitutes were applied to full-thickness wounds. Healing was assessed at days 7, 14, and 21 through visual inspection and histological analysis 1 .
| Substitute Type | Healing Performance | Key Strengths | Limitations |
|---|---|---|---|
| BTES (Bilayered) | Best overall healing | Promotes both re-epithelialization and dermal reconstruction | More complex manufacturing process |
| SLTES-K (Keratinocytes only) | Moderate healing | Supports epidermal barrier restoration | Limited dermal regeneration |
| SLTES-F (Fibroblasts only) | Moderate healing | Improves dermal matrix formation | Limited epidermal coverage |
After three weeks of implantation, histological examination through hematoxylin-eosin, Masson trichrome, and elastin van Gieson staining revealed that:
These findings strongly suggest that the coordinated interaction between keratinocytes and fibroblasts in a biomimetic layered structure creates a synergistic effect that enhances the healing process beyond what either cell type can accomplish alone.
This research represents more than just an academic exercise—it points toward a future where patients with devastating burns or chronic wounds can receive effective treatments using their own cells. The potential applications are significant:
Diabetic foot ulcers and venous leg ulcers that resist conventional treatment might respond to bioactive skin substitutes 8 .
Emerging evidence suggests that well-designed tissue-engineered skin may promote more regenerative healing with less scarring 4 .
Using a patient's own cells eliminates rejection risk and creates perfectly matched tissue 1 .
While challenges remain—including standardization of biomaterial properties and scaling up manufacturing processes—the future of tissue-engineered skin is remarkably promising. As one review noted, while the number of preclinical studies has increased dramatically, this hasn't yet translated into a wide variety of clinical applications . However, with continued research and clinical validation, bilayered skin substitutes using autologous keratinocytes and fibroblasts with fibrin represent a potentially transformative alternative to traditional skin grafting.
The journey from concept to clinical reality continues, but each advance brings us closer to a future where we can truly engineer healing from the cellular level up—offering hope to millions who suffer from wounds that currently defy treatment.